Building on Ties with Japanese Market

News

 Building on Ties with Japanese Market

06 Aug, 2020

Published over 5 years ago. See the latest and most current information on News.

SPT Labtech Ltd has opened an office in Japan, following long-standing partnerships with Japanese life science distributors. The new facility, the company’s second site in the APAC region, will be headed by Masahiro Matsushita as Director.

The company’s move to further improve the connection to its customers in Japan was also motivated by the growing Biotech and Healthcare markets in Japan, particularly the reased investment in valued techniques such as NGS and cryo-EM.

David Newble, Managing Director of SPT Labtech said, “Our ambition is to strengthen the company’s partnerships within the Japanese market and the establishment of a team in Japan will enable SPT Labtech to meet the needs of this community more effectively. From our existing sector presence, there is already much interest for our products and through collaboration, deep application knowledge and world-leading engineering, we look forward to working with more life scientists to help accelerate and elevate their research.”

“With a flourishing Life Sciences industry in Japan and increasing adoption of laboratory automation, this is an ideal time for SPT Labtech to fully embed themselves in the region. With the opening of the new office we are looking ahead to a collaborative future that will benefit clients and the life sciences community in Japan,” added Masahiro Matsushita.

ILM Guide 2026/27

Explore our Digital Edition

Discover the latest news and research

Digital edition

Explore Our Other Sites

Envirotech Online
Do we need to widen our sampling sources for PFAS contamination?
Explore more Arrow
Pollution Solutions Online
Next-generation reverse osmosis membranes for more efficient and cost-effective seawater desalination
Explore more Arrow
Petro Online
Three generations of innovation. One powerful new platform
Explore more Arrow
Chromatography Today
Wiley expands forensic drug database for faster identification of designer drugs
Explore more Arrow